Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
New York Weill Cornell Cancer Center at Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Mount Sinai Hospital
mi
from
New York, NY
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - Syracuse
mi
from
Syracuse, NY
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - Syracuse
mi
from
Syracuse, NY
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - Asheville
mi
from
Asheville, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - Asheville
mi
from
Asheville, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
NorthEast Oncology Associates - Concord
mi
from
Concord, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
NorthEast Oncology Associates - Concord
mi
from
Concord, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - Durham
mi
from
Durham, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - Durham
mi
from
Durham, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Cape Fear Valley Health System
mi
from
Fayetteville, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Cape Fear Valley Health System
mi
from
Fayetteville, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Lenoir Memorial Cancer Center
mi
from
Kinston, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Lenoir Memorial Cancer Center
mi
from
Kinston, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Comprehensive Cancer Center at Moore Regional Hospital
mi
from
Pinehurst, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Comprehensive Cancer Center at Moore Regional Hospital
mi
from
Pinehurst, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Zimmer Cancer Center at New Hanover Regional Medical Center
mi
from
Wilmington, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Zimmer Cancer Center at New Hanover Regional Medical Center
mi
from
Wilmington, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
mi
from
Columbus, OH
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Oklahoma University Medical Center
mi
from
Oklahoma City, OK
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Oklahoma University Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Western Pennsylvania Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Lifespan: The Miriam Hospital
mi
from
Providence, RI
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Lifespan: The Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
University of Tennessee Cancer Institute at Methodist Central Hospital
mi
from
Memphis, TN
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
University of Tennessee Cancer Institute at Methodist Central Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - Memphis
mi
from
Memphis, TN
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - Dallas
mi
from
Dallas, TX
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Vermont Cancer Center at University of Vermont
mi
from
Burlington, VT
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Vermont Cancer Center at University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Martha Jefferson Hospital
mi
from
Charlottesville, VA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Martha Jefferson Hospital
mi
from
Charlottesville, VA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Virginia Oncology Associates - Norfolk
mi
from
Norfolk, VA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Virginia Oncology Associates - Norfolk
mi
from
Norfolk, VA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
Oncology and Hematology Associates of Southwest Virginia, Incorporated - Roanoke
mi
from
Roanoke, VA
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
Oncology and Hematology Associates of Southwest Virginia, Incorporated - Roanoke
mi
from
Roanoke, VA
Click here to add this to my saved trials
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated:  6/30/2016
St Mary's Medical Center
mi
from
Huntington, WV
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma
Status: Enrolling
Updated: 6/30/2016
St Mary's Medical Center
mi
from
Huntington, WV
Click here to add this to my saved trials
Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer
Phase I/II Double Blinded Randomized Study to Determine the Tolerability and Efficacy of 2 Different Doses of Revlimid (CC-5013, Lenalidomide) in Biochemically Relapsed Prostate Cancer Patients (M0) After Local Treatment
Status: Enrolling
Updated:  6/30/2016
The Harry and Jeanette Weinberg Building
mi
from
Baltimore, MD
Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer
Phase I/II Double Blinded Randomized Study to Determine the Tolerability and Efficacy of 2 Different Doses of Revlimid (CC-5013, Lenalidomide) in Biochemically Relapsed Prostate Cancer Patients (M0) After Local Treatment
Status: Enrolling
Updated: 6/30/2016
The Harry and Jeanette Weinberg Building
mi
from
Baltimore, MD
Click here to add this to my saved trials
Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma
Status: Enrolling
Updated:  6/30/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma
Status: Enrolling
Updated: 6/30/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
Pilot Study of Ranibizumab (Lucentis) for Neurofibromas Associated With Neurofibromatosis 1
Status: Enrolling
Updated:  7/6/2016
Massachusetts General Hospital
mi
from
Boston, MA
Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
Pilot Study of Ranibizumab (Lucentis) for Neurofibromas Associated With Neurofibromatosis 1
Status: Enrolling
Updated: 7/6/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
CT in Diagnosing Patients With Lung Cancer
Comparison of Conventional Free Breathing CT, 4D CT, and Integrated Active Breath Hold CT Image Acquisition for Lung Cancer
Status: Enrolling
Updated:  7/6/2016
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
CT in Diagnosing Patients With Lung Cancer
Comparison of Conventional Free Breathing CT, 4D CT, and Integrated Active Breath Hold CT Image Acquisition for Lung Cancer
Status: Enrolling
Updated: 7/6/2016
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
University of Alabama at Birmingham, Comprehensive Cancer Center
mi
from
Birmingham, AL
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
University of Alabama at Birmingham, Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
Foundation for Cancer Research and Education
mi
from
Phoenix, AZ
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
Foundation for Cancer Research and Education
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
Mount Diablo Regional Cancer Center
mi
from
Concord, CA
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
Mount Diablo Regional Cancer Center
mi
from
Concord, CA
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
Sutter Cancer Center
mi
from
Sacramento, CA
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
Sutter Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
John Muir Comprehensive Cancer Center at John Muir Medical Center
mi
from
Walnut Creek, CA
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
John Muir Comprehensive Cancer Center at John Muir Medical Center
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
University of Colorado Cancer Center at University of Colorado Health Sciences Center
mi
from
Aurora, CO
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
University of Colorado Cancer Center at University of Colorado Health Sciences Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
Yale Comprehensive Cancer Center
mi
from
New Haven, CT
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
Yale Comprehensive Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
Shands Cancer Center at the University of Florida Health Science Center
mi
from
Gainesville, FL
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
Shands Cancer Center at the University of Florida Health Science Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
University of Illinois Medical Center
mi
from
Chicago, IL
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
University of Illinois Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
Genesis Regional Cancer Center at Genesis Medical Center
mi
from
Davenport, IA
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
Genesis Regional Cancer Center at Genesis Medical Center
mi
from
Davenport, IA
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
mi
from
Kansas City, KA
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated:  7/6/2016
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase III Randomized Trial Of The Role Of Whole Brain Radiation Therapy In Addition To Radiosurgery In The Management Of Patients With One To Three Cerebral Metastases
Status: Enrolling
Updated: 7/6/2016
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials